Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Nieto-García

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Allergy and Clinical Immunology|April 3, 2024
Biological treatments in childhood asthmaAntonio Nieto-García, María Nieto-Cid, Ángel Mazón-Ramos
Frontiers in Allergy|February 21, 2024
360° approach to the patient with mite allergy: from scientific evidence to clinical practiceAntonio Nieto-García, Eva Abel-Fernández, María Nieto-Cid, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 31, 2012
Allergy alerts in electronic health records for hospitalized patientsRebeca González-Gregori, M Dolores Hernández Fernandez De Rojas, Ramón López-Salgueiro, et al.
The World Allergy Organization Journal|January 4, 2013
Allergy Diagnosis in Children and Adults: Performance of a New Point-of-Care Device, ImmunoCAP RapidGunilla Hedlin, Carmen Moreno, Carl Johan Petersson, et al.
Nutrients|January 11, 2025
Growth, Safety and Tolerance in Infants Fed Rice Protein Hydrolysate Formula: The GRITO Randomised Controlled TrialAnaïs Lemoine, Antonio Nieto-García, María Nieto-Cid, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 23, 2021
Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthmaAntonio Nieto García, Teresa Garriga-Baraut, Ana María Plaza Martín, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 27, 2023
Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in SpainMaría Nieto-Cid, Teresa Garriga-Baraut, Ana Mª Plaza-Martín, et al.
ERJ Open Research|August 19, 2021
Biologicals in childhood severe asthma: the European PERMEABLE survey on the <i>status quo</i>Elisangela Santos-Valente, Heike Buntrock-Döpke, Rola Abou Taam, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Allergy and Clinical Immunology|April 3, 2024
Biological treatments in childhood asthmaAntonio Nieto-García, María Nieto-Cid, Ángel Mazón-Ramos
Frontiers in Allergy|February 21, 2024
360° approach to the patient with mite allergy: from scientific evidence to clinical practiceAntonio Nieto-García, Eva Abel-Fernández, María Nieto-Cid, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 31, 2012
Allergy alerts in electronic health records for hospitalized patientsRebeca González-Gregori, M Dolores Hernández Fernandez De Rojas, Ramón López-Salgueiro, et al.
The World Allergy Organization Journal|January 4, 2013
Allergy Diagnosis in Children and Adults: Performance of a New Point-of-Care Device, ImmunoCAP RapidGunilla Hedlin, Carmen Moreno, Carl Johan Petersson, et al.
Nutrients|January 11, 2025
Growth, Safety and Tolerance in Infants Fed Rice Protein Hydrolysate Formula: The GRITO Randomised Controlled TrialAnaïs Lemoine, Antonio Nieto-García, María Nieto-Cid, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 23, 2021
Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthmaAntonio Nieto García, Teresa Garriga-Baraut, Ana María Plaza Martín, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 27, 2023
Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in SpainMaría Nieto-Cid, Teresa Garriga-Baraut, Ana Mª Plaza-Martín, et al.
ERJ Open Research|August 19, 2021
Biologicals in childhood severe asthma: the European PERMEABLE survey on the <i>status quo</i>Elisangela Santos-Valente, Heike Buntrock-Döpke, Rola Abou Taam, et al.
Pageof 1